Covea Finance’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-39,594
Closed -$1.45M 131
2022
Q4
$1.45M Hold
39,594
0.07% 117
2022
Q3
$1.87M Hold
39,594
0.1% 108
2022
Q2
$2.84M Buy
39,594
+5,000
+14% +$366K 0.4% 36
2022
Q1
$2.8M Hold
34,594
0.31% 39
2021
Q4
$3.55M Buy
+34,594
New +$3.32M 0.31% 36

Other funds holding SYNH

Covea Finance's SYNH Position: Q1 2023 in Review

Covea Finance sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 39,594 shares — an estimated $1.45M sold.

Covea Finance first reported a position in SYNH in Q4 2021 and held it in 5 quarters. The position peaked at $3.55M in Q4 2021. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

  • Covea Finance reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Covea Finance sold 39,594 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $1.45M.
  • Covea Finance first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2021 and held it in 5 quarters.
  • Covea Finance's Syneos Health, Inc. Class A Common Stock position peaked at $3.55M in Q4 2021.
  • 305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on Covea Finance's 13F filing for Q1 2023, filed 17 Apr 2023.